Patents by Inventor Mary Jane DUERMEYER

Mary Jane DUERMEYER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Viral vectors for cancer therapy
    Patent number: 11918660
    Abstract: The present disclosure provides recombinant nucleic acids comprising one or more polynucleotides encoding an immunomodulatory polypeptide (e.g., a pro-inflammatory cytokine such as a human IL-2 or IL-12 polypeptide); viruses comprising the recombinant nucleic acids; compositions and formulations comprising the recombinant nucleic acids and/or viruses; methods of their use (e.g., for the treatment of cancer, such as lung cancer); and articles of manufacture or kits thereof.
    Type: Grant
    Filed: March 8, 2023
    Date of Patent: March 5, 2024
    Assignee: Krystal Biotech, Inc.
    Inventors: Suma Krishnan, Trevor Parry, Dana Michelle Previte, Mary Jane Duermeyer
  • VIRAL VECTORS FOR CANCER THERAPY
    Publication number: 20230338583
    Abstract: The present disclosure provides recombinant nucleic acids comprising one or more polynucleotides encoding an immunomodulatory polypeptide (e.g., a pro-inflammatory cytokine such as a human IL-2 or IL-12 polypeptide); viruses comprising the recombinant nucleic acids; compositions and formulations comprising the recombinant nucleic acids and/or viruses; methods of their use (e.g., for the treatment of cancer, such as lung cancer); and articles of manufacture or kits thereof.
    Type: Application
    Filed: May 12, 2023
    Publication date: October 26, 2023
    Applicant: Krystal Biotech, Inc.
    Inventors: Suma KRISHNAN, Trevor PARRY, Dana Michelle PREVITE, Mary Jane DUERMEYER
  • Viral vectors for cancer therapy
    Patent number: 11779660
    Abstract: The present disclosure provides recombinant nucleic acids comprising one or more polynucleotides encoding an immunomodulatory polypeptide (e.g., a pro-inflammatory cytokine such as a human IL-2 or IL-12 polypeptide); viruses comprising the recombinant nucleic acids; compositions and formulations comprising the recombinant nucleic acids and/or viruses; methods of their use (e.g., for the treatment of cancer, such as lung cancer); and articles of manufacture or kits thereof.
    Type: Grant
    Filed: April 1, 2022
    Date of Patent: October 10, 2023
    Assignee: Krystal Biotech, Inc.
    Inventors: Suma Krishnan, Trevor Parry, Dana Michelle Previte, Mary Jane Duermeyer
  • VIRAL VECTORS FOR CANCER THERAPY
    Publication number: 20230241251
    Abstract: The present disclosure provides recombinant nucleic acids comprising one or more polynucleotides encoding an immunomodulatory polypeptide (e.g., a pro-inflammatory cytokine such as a human IL-2 or IL-12 polypeptide); viruses comprising the recombinant nucleic acids; compositions and formulations comprising the recombinant nucleic acids and/or viruses; methods of their use (e.g., for the treatment of cancer, such as lung cancer); and articles of manufacture or kits thereof.
    Type: Application
    Filed: March 8, 2023
    Publication date: August 3, 2023
    Applicant: Krystal Biotech, Inc.
    Inventors: Suma KRISHNAN, Trevor PARRY, Dana Michelle PREVITE, Mary Jane DUERMEYER
  • VIRAL VECTORS FOR CANCER THERAPY
    Publication number: 20220323613
    Abstract: The present disclosure provides recombinant nucleic acids comprising one or more polynucleotides encoding an immunomodulatory polypeptide (e.g., a pro-inflammatory cytokine such as a human IL-2 or IL-12 polypeptide); viruses comprising the recombinant nucleic acids; compositions and formulations comprising the recombinant nucleic acids and/or viruses; methods of their use (e.g., for the treatment of cancer, such as lung cancer); and articles of manufacture or kits thereof.
    Type: Application
    Filed: April 1, 2022
    Publication date: October 13, 2022
    Applicant: Krystal Biotech, Inc.
    Inventors: Suma KRISHNAN, Trevor PARRY, Dana Michelle PREVITE, Mary Jane DUERMEYER